HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 201 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,067 | +72.9% | 20,382 | +34.3% | 0.00% | +100.0% |
| Q1 2024 | $617 | -0.3% | 15,172 | -9.5% | 0.00% | 0.0% |
| Q4 2023 | $619 | 0.0% | 16,758 | +3.3% | 0.00% | 0.0% |
| Q3 2023 | $619 | +8.2% | 16,216 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $572 | -2.1% | 15,869 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $584 | -54.2% | 15,318 | -31.7% | 0.00% | -66.7% |
| Q4 2022 | $1,275 | -99.9% | 22,425 | -17.9% | 0.00% | 0.0% |
| Q3 2022 | $1,080,000 | -9.9% | 27,322 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $1,199,000 | +54.3% | 27,271 | +39.9% | 0.00% | +50.0% |
| Q1 2022 | $777,000 | -0.8% | 19,494 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $783,000 | +5.1% | 19,494 | +6.4% | 0.00% | 0.0% |
| Q3 2021 | $745,000 | -13.4% | 18,324 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $860,000 | -6.7% | 18,958 | -14.3% | 0.00% | -33.3% |
| Q1 2021 | $922,000 | -1.9% | 22,128 | +0.4% | 0.00% | 0.0% |
| Q4 2020 | $940,000 | +21.4% | 22,032 | -25.3% | 0.00% | 0.0% |
| Q3 2020 | $774,000 | -2.1% | 29,485 | -0.2% | 0.00% | 0.0% |
| Q2 2020 | $791,000 | +39.5% | 29,535 | -6.3% | 0.00% | 0.0% |
| Q1 2020 | $567,000 | +1.1% | 31,535 | -0.5% | 0.00% | +50.0% |
| Q4 2019 | $561,000 | -19.4% | 31,695 | -29.4% | 0.00% | -33.3% |
| Q3 2019 | $696,000 | -9.7% | 44,890 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $771,000 | +9.4% | 44,890 | +2.4% | 0.00% | 0.0% |
| Q1 2019 | $705,000 | +10.3% | 43,840 | +0.3% | 0.00% | 0.0% |
| Q4 2018 | $639,000 | -80.6% | 43,730 | -75.9% | 0.00% | -81.2% |
| Q3 2018 | $3,290,000 | +79.2% | 181,108 | +66.4% | 0.02% | +60.0% |
| Q2 2018 | $1,836,000 | -12.2% | 108,829 | +2.0% | 0.01% | -9.1% |
| Q1 2018 | $2,090,000 | 0.0% | 106,729 | +3.4% | 0.01% | 0.0% |
| Q4 2017 | $2,090,000 | – | 103,176 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |